期刊文献+

BRCA1基因在散发性乳腺癌中的表达及异常甲基化 被引量:5

Expression and abnormal methylation BRCA1 in sporadic breast cancer
下载PDF
导出
摘要 目的通过检测乳腺癌易感基因1(BRCA1)基因在散发性乳腺癌中的表达情况及其启动子甲基化状态,探讨BRCA1基因与散发性乳腺癌的关系。方法应用实时荧光定量PCR的方法和免疫组织化学方法分别检测BRCA1mRNA和蛋白在60例散发性乳腺癌组织、癌旁正常乳腺组织及30例乳腺良性病变组织中的表达情况;应用重亚硫酸盐测序PCR(BPS)联合TA克隆测序方法检测上述组织中BRCA1启动子CpG岛的甲基化状态,分析BRCA1基因表达和启动子甲基化相关性。结果 BRCA1mRNA和蛋白在散发性乳腺癌组织中的相对表达水平分别低于癌旁正常组织及乳腺良性病变组织,差异有统计学意义(P<0.001)。乳腺癌组织中BRCA1蛋白的表达率为51.7%(31/60),明显低于癌旁正常乳腺组织的71.7%(43/60)及乳腺良性病变组织的66.7%(20/30),差异有统计学意义(P<0.001);散发性乳腺癌组织中BRCA1启动子甲基化率为31.7%(19/60),癌旁正常乳腺组织及乳腺良性病变组织均未检测出甲基化,差异有统计学意义(P=0.000);BRCA1蛋白表达与其启动子甲基化呈负相关(r=-0.345,P=0.007)。结论乳腺癌易感基因BRCA1启动子区CpG岛甲基化导致BRCA1基因表达显著下调,可能参与散发性乳腺癌的发生、发展。 Objective To investigate expression and promoter methylation status of BRCA1 in sporadic breast cancer .Meth-ods The expression of BRCA1 mRNA and protein were detected in 60 cases of sporadic breast cancer ,the adjacent breast tissues , and 30 cases of breast benign lesion tissue by RT-PCR and and immunohistochemical staining respectively .The methylation status of BRCA1 promoter in those tissues were detected using bisulfite genomic sequencing PCR (BSP) combined with TA clone for se-quencing .The relation between BRCA1 expression in sporadic breast cancer and promoter methylation status was analyzed .Results The expression level of BRCA1 mRNA and protein were down-regulated in sporadic breast cancer tissues compared to the corre-sponding adjacent breast tissues and breast benign lesion tissue(P〈0 .001) .The positive rates of BRCA1 protein was 51 .7% (31/60)in sporadic breast tissue ,which were significantly lower than those of in the adjacent breast tissues 71 .7% (43/60)and breast benign lesion tissue 66 .7% (20/30)(P〈 0 .001) .The methylation rate of BRCA1 promoter CpG was 31 .7% (19/60)in sporadic breast ,while it wasn′t found in adjacent breast tissues and breast benign lesion tissue(P=0 .000) .The statistical analysis showed the expression of BRCA1 had significant negative correlation with promoter methylation(r= -0 .345 ,P=0 .007) .Conclusion The hypermethylation of BRCA1 promoter could induce BRCA1 down-regulating ,which may be involved in the occurrence and develop-ment of sporadic breast cancer .
出处 《重庆医学》 CAS 北大核心 2015年第9期1174-1176,共3页 Chongqing medicine
基金 广西自然科学青年基金资助项目(2011GXNSFB018102)
关键词 乳腺肿瘤 BRCA1 基因 甲基化 breast neoplasms gene methylation
  • 相关文献

参考文献14

  • 1Zakhartseva LM, Gorovenko NG, Podolskaya SV, et al. Breast cancer immunohistochemlcal features in young women with BRCA 1/2 mutations[J]. Exp Oncol,2009, 31(3):174-178.
  • 2King MC, Marks J H, Mandell JB, et al. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2[J]. Science,2003,302(5645) :643-646.
  • 3Chenevix-Trench G, Healey S, Lakhani S, et ai. Genetic and histopathologic evaluation of BRCA1 and BRCA2DNA sequence variant s of an known clinical significance[J]. Cancer Res,2006,66(4) :2019-2027.
  • 4Bonatti F,Pepe C, Tancredi M, et al. RNA-based analysis of BRCA1 and BRCA2 gene alterations[J]. Cancer Genet Cytogenet, 2006,170(2) :93-101.
  • 5任婕,魏敏杰,金锋,米小轶,王麟,冯婉玉,金万宝.散发性乳腺癌中影响BRCA1蛋白失表达的参数分析[J].中国肿瘤临床,2008,35(2):99-103. 被引量:8
  • 6De Siervi A,De Luca P,Byun JS,et al. Transcriptional au toregulation by BRCA1 [J]. Cancer Res, 2010,70 ( 2 ) : 532-542.
  • 7Morris JR,Boutell C,Keppler M,et al. The SUMO modi fication pathway is involved in the BRCA1 response to genotoxic stress[J]. Nature,2009,462(7275) :886-890.
  • 8Milne RL,Antoniou AC. Genetic modifiers of cancer risk for BRCA1 and BRCA2 mutation carriers[J]. Ann Oncol, 2011,22 Suppt 1:i11-7.
  • 9Fulan D, Sahnane N, Bernasconi B, et al. APC alterations are frequently involved in the pathogenesis of acinar cell carcinoma of the pancreas, mainly through gene loss and promoter hypermethylation[J]. Virchows Arch, 2014,464 (5) :553-564.
  • 10Fiolka R, Zubor P,Janusicova V, et al. Promoter hyperm ethylation of the tumor-suppressor genes RASSFIA. GSTP1 and CDH1 in endometrial cancer[J]. Oncol Rep, 2013,30(6) :2878-2886.

二级参考文献14

  • 1朱孝峰,周军民,谢冰芬,冯公侃,刘宗潮,曾益新.HER2/neu受体酪氨酸激酶抑制剂SUCI02对乳腺癌细胞周期的影响及其分子机理[J].中国肿瘤临床,2004,31(22):1261-1264. 被引量:4
  • 2任婕,魏敏杰,金锋,杨栋,林哲珠,马文峰,金万宝.散发性乳腺癌组织中BRCA1基因启动子甲基化与蛋白表达的相关性[J].中华肿瘤防治杂志,2007,14(3):161-164. 被引量:12
  • 3Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002 [J]. CA Cancer J Clin, 2005, 55(2): 74-108
  • 4Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 [J]. Science, 1994, 266(5182): 66-71
  • 5Bonatti F, Pepe C, Tancredi M, et al. RNA-based analysis of BRCA1 and BRGA2 gene alterations[J]. Cancer Genet Cytogenet, 2006, 170(2): 93-101
  • 6Lambie H, Miremadi A, Pinder SE, et al. Prognostic significance of BRCA1 expression in sporadic breast carcinomas [J]. J Pathol, 2003, 200(2): 207-213
  • 7Bast RC Jr, Ravdin P, Hayes DF, et al. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology[J].J Clin Oncol, 2001, 19(6): 1865-1878
  • 8Wei M, Grushko TA, Dignam J, et al. BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy [J]. Cancer Res, 2005, 65 (23): 10692-10699
  • 9Chart KY, Ozcelik H, Cheung AN, et al. Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer [J]. Cancer Res, 2002, 62(14): 4151-4156
  • 10James CR, Quinn JE, Mullah PB, et al. BRCA1, a potential predictive biomarker in the treatment of breast cancer [J]. Oncologist, 2007, 12(2): 142-150

共引文献7

同被引文献39

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部